Cartesian Therapeutics, Inc. (RNAC)
8.16
-0.18
(-2.16%)
USD |
NASDAQ |
May 07, 15:44
Cartesian Therapeutics Free Cash Flow : -77.37M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insmed, Inc. | -997.58M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Precision BioSciences, Inc. | -54.23M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.14M |
| Cash from Investing (Quarterly) | -0.027M |
| Cash from Financing (Quarterly) | 15.67M |
| Free Cash Flow Per Share (Quarterly) | -0.8252 |
| Free Cash Flow to Equity (Quarterly) | -21.34M |
| Free Cash Flow to Firm (Quarterly) | -22.16M |
| Free Cash Flow Yield | -36.01% |